- ICH GCP
- EU klinikai vizsgálatok nyilvántartása
Klinikai vizsgálatok Nct
Clinical Trial Results:
A Cancer Research UK Randomised Multicentre Phase II Trial of the DNA-hypomethylating Agent, 5-Aza-2'-deoxycytidine(Decitabine) given intravenously in Combination with Carboplatin, versus Carboplatin alone given 4 weekly in patients with progressive, advanced Ovarian cancer.
Due to the EudraCT – Results system being out of service between 31 July 2015 and 12 January 2016, these results have been published in compliance with revised timelines
Summary | |
EudraCT number | 2006-002324-41 |
Trial protocol | GB |
Global completion date | 17 Dec 2008 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 29 Dec 2016 |
First version publication date | 29 Dec 2016 |
Other versions | |
Summary report(s) | DACROC Results Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.